New Therapeutics Targets in Chronic Viral Cardiomyopathy
- 512 Downloads
Dilated cardiomyopathy (DCM) is a prevalent heart muscle disease characterized by impaired contractility and dilation of the ventricles. Recent clinical research suggests that cardiotropic viruses are important environmental pathogenic factors in human DCM, which may therefore be considered as a chronic viral cardiomyopathy. All virus-positive DCM patients thus come into the focus of virological research and should be considered for antiviral strategies. Interferon-β therapy has been shown to mediate virus elimination in patients with adenovirus or coxsackievirus persistence.We discuss here several possible new molecular targets for patients infected with cardiotropic viruses in (1) the cellular virus uptake system, (2) virus-induced cellular signaling pathways, and (3) interactions between virus-encoded proteins with important cellular target proteins. The potential of these approaches in the setting of a chronic viral infection is significantly different from that in an acute viral infection. Specific problems encountered in a chronic situation and possible solutions are discussed.
KeywordsDilate Cardiomyopathy Innate Immune Signaling CVB3 Infection Experimental Autoimmune Myocarditis Lymphocytic Myocarditis
- Nigro G, Bastianon V, Colloridi V, et al (2000) Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review. Clin Microbiol Infect 31:65–69Google Scholar
- Ping YH, Chu CY, Cao H, Jacque JM, Stevenson M, Rana TM (2004) Modulating HIV-1 replication by RNA interference directed against human transcription elongation factor SPT5. J Acquir Immune Defic Syndr Hum Retrovirol 1:46Google Scholar
- Poller W, Kuhl U, Tschoepe C, Pauschinger M, Fechner H, Schultheiss HP (2005) Genome-environment interactions in the molecular pathogenesis of dilated cardiomyopathy. J Molec Med [Epub head of print 2 June 2005]Google Scholar
- Xiong D, Lee G-H, Badorff C, et al. (2002) Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: A genetic predisposition to viral heart disease. Nat Med 8:782–877Google Scholar